Proficio Capital Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-238
| Closed | -$20K | – | 320 |
|
|
2019
Q2 | $20K | Sell |
238
-228
| -49% | -$19.2K | 0.01% | 682 |
|
|
2019
Q1 | $41K | Buy |
466
+6
| +1% | +$528 | 0.01% | 408 |
|
|
2018
Q4 | $39K | Sell |
460
-31
| -6% | -$2.63K | 0.02% | 356 |
|
|
2018
Q3 | $48K | Buy |
491
+6
| +1% | +$587 | 0.02% | 361 |
|
|
2018
Q2 | $46K | Buy |
485
+307
| +172% | +$29.1K | 0.02% | 372 |
|
|
2018
Q1 | $14K | Sell |
178
-38
| -18% | -$2.99K | ﹤0.01% | 689 |
|
|
2017
Q4 | $19K | Sell |
216
-3
| -1% | -$264 | 0.01% | 594 |
|
|
2017
Q3 | $20K | Sell |
219
-382
| -64% | -$34.9K | 0.01% | 589 |
|
|
2017
Q2 | $53K | Buy |
601
+50
| +9% | +$4.41K | 0.02% | 368 |
|
|
2017
Q1 | $49K | Buy |
551
+361
| +190% | +$32.1K | 0.02% | 386 |
|
|
2016
Q4 | $16K | Buy |
190
+56
| +42% | +$4.72K | 0.01% | 504 |
|
|
2016
Q3 | $12K | Buy |
134
+104
| +347% | +$9.31K | 0.01% | 538 |
|
|
2016
Q2 | $3K | Sell |
30
-13
| -30% | -$1.3K | ﹤0.01% | 763 |
|
|
2016
Q1 | $4K | Buy |
43
+9
| +26% | +$837 | ﹤0.01% | 544 |
|
|
2015
Q4 | $4K | Buy |
+34
| New | +$4K | ﹤0.01% | 456 |
|